Aadi Bioscience Announces Approval of All Proposals at Special Meeting of Stockholders
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 03 2025
0mins
Source: PRnewswire
Stockholder Approvals: Aadi Bioscience's stockholders approved several proposals during a Special Meeting, including the divestiture of its FYARRO business to KAKEN INVESTMENTS INC., a PIPE financing proposal for issuing shares, and an increase in the equity plan shares available.
Future Plans: The company aims to enhance its equity incentive plan and has received a non-binding advisory vote regarding executive compensation related to the divestiture, with final voting results to be reported in a Form 8-K.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
